[
  {
    "ts": "2025-11-24T01:45:50+00:00",
    "headline": "Dow Jones Futures, Bitcoin Rise; Nvidia, Apple, Eli Lilly In Focus",
    "summary": "The stock market needs to show a lot of strength after damaging recent losses. Watch Nvidia, Apple and Eli Lilly.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-bitcoin-nvidia-apple-eli-lilly/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "8d419152-1254-303b-b245-e33cbbfa30b6",
      "content": {
        "id": "8d419152-1254-303b-b245-e33cbbfa30b6",
        "contentType": "STORY",
        "title": "Dow Jones Futures, Bitcoin Rise; Nvidia, Apple, Eli Lilly In Focus",
        "description": "",
        "summary": "The stock market needs to show a lot of strength after damaging recent losses. Watch Nvidia, Apple and Eli Lilly.",
        "pubDate": "2025-11-24T01:45:50Z",
        "displayTime": "2025-11-24T01:45:50Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8d419152-1254-303b-b245-e33cbbfa30b6/dow-jones-futures-bitcoin.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/5fdd3c5f0f89e222467a493284270e2d",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FzBAU3NicsQkEEHCoO3zGQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/5fdd3c5f0f89e222467a493284270e2d.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gx1A6_cnIfTHdGpP8TvdPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/5fdd3c5f0f89e222467a493284270e2d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-bitcoin-nvidia-apple-eli-lilly/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "MEDP"
            },
            {
              "symbol": "RTX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T00:10:00+00:00",
    "headline": "Billionaire Stanley Druckenmiller Dropped Nvidia, Palantir, and Eli Lilly Over the Past Year and Just Bought the 2 Cheapest Magnificent Seven Stocks.",
    "summary": "These Magnificent Seven players are well-positioned to benefit in the AI boom.",
    "url": "https://www.fool.com/investing/2025/11/23/billionaire-stanley-druckenmiller-dropped-nvidia-p/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f4127649-2ff2-32c7-8974-cd33205f6066",
      "content": {
        "id": "f4127649-2ff2-32c7-8974-cd33205f6066",
        "contentType": "STORY",
        "title": "Billionaire Stanley Druckenmiller Dropped Nvidia, Palantir, and Eli Lilly Over the Past Year and Just Bought the 2 Cheapest Magnificent Seven Stocks.",
        "description": "",
        "summary": "These Magnificent Seven players are well-positioned to benefit in the AI boom.",
        "pubDate": "2025-11-24T00:10:00Z",
        "displayTime": "2025-11-24T00:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/5ac07ab10c44181846d3041d4cbf31b4",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Investors gather around a computer in an office.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/P4AuuH.9K7enZpCsGz_Mng--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/5ac07ab10c44181846d3041d4cbf31b4.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.KblB9I68SuPCkK6f0UlNQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/5ac07ab10c44181846d3041d4cbf31b4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/23/billionaire-stanley-druckenmiller-dropped-nvidia-p/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/billionaire-stanley-druckenmiller-dropped-nvidia-001000612.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T10:29:00+00:00",
    "headline": "These Stocks Are Moving the Most Today: Tesla, Alphabet, Strategy, Eli Lilly, and More",
    "summary": "Investors are hopeful that the economic data due out this week will strengthen the case for a Fed rate cut. These stocks are rising.",
    "url": "https://www.barrons.com/articles/stock-movers-37fe692a?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e8391264-b308-336f-9e5c-89bbd17a76f3",
      "content": {
        "id": "e8391264-b308-336f-9e5c-89bbd17a76f3",
        "contentType": "STORY",
        "title": "These Stocks Are Moving the Most Today: Tesla, Alphabet, Strategy, Eli Lilly, and More",
        "description": "",
        "summary": "Investors are hopeful that the economic data due out this week will strengthen the case for a Fed rate cut. These stocks are rising.",
        "pubDate": "2025-11-24T10:29:00Z",
        "displayTime": "2025-11-24T10:29:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e8391264-b308-336f-9e5c-89bbd17a76f3/these-stocks-are-moving-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/3ca59d8914afa984af63f16053239638",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jwAkyjmFR03FANWo9YOSWQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/3ca59d8914afa984af63f16053239638.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Li546X3HiP_kcVLFyHoaVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/3ca59d8914afa984af63f16053239638.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-37fe692a?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "STRC"
            },
            {
              "symbol": "STRD"
            },
            {
              "symbol": "STRF"
            },
            {
              "symbol": "STRK"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T12:17:09+00:00",
    "headline": "Novo Nordisk Dives As Ozempic Fails To Slow Alzheimer's; Lilly Falls, Biogen Jumps",
    "summary": "Novo Nordisk reported Monday that a Ozempic pill failed to slow the progression of Alzheimer's in two big studies. Novo dived, Eli Lilly fell. Biogen rose.",
    "url": "https://www.investors.com/news/novo-nordisk-dives-ozempic-fails-slow-alzheimers-eli-lilly-biogen/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "a51cd60d-fe17-396c-bf06-7516a239f75c",
      "content": {
        "id": "a51cd60d-fe17-396c-bf06-7516a239f75c",
        "contentType": "STORY",
        "title": "Novo Nordisk Dives As Ozempic Fails To Slow Alzheimer's; Lilly Falls, Biogen Jumps",
        "description": "",
        "summary": "Novo Nordisk reported Monday that a Ozempic pill failed to slow the progression of Alzheimer's in two big studies. Novo dived, Eli Lilly fell. Biogen rose.",
        "pubDate": "2025-11-24T12:17:09Z",
        "displayTime": "2025-11-24T12:17:09Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a51cd60d-fe17-396c-bf06-7516a239f75c/novo-nordisk-dives-as-ozempic.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/817e6030ee2ae5f493a5abec2e2fbfba",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7obXGavYr8kgk3K.Mtzb2w--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/817e6030ee2ae5f493a5abec2e2fbfba.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jzjG937xziJt0639IwSv.A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/817e6030ee2ae5f493a5abec2e2fbfba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/novo-nordisk-dives-ozempic-fails-slow-alzheimers-eli-lilly-biogen/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T12:16:22+00:00",
    "headline": "Novo Nordisk Stock Price Falls After Ozempic Fails to Slow Alzheimer's",
    "summary": "Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit weight-loss drugs didn't slow the progress of Alzheimer's disease.    Novo Nordisk stock recently stood about 10% lower, on pace for its lowest close since July 2021, according to Dow Jones Market Data.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-24-2025/card/novo-nordisk-stock-price-falls-after-ozempic-fails-to-slow-alzheimer-s-dUT2l9aQtS1u7r0KxJQZ?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "8e47a6ba-5720-39ab-9b12-6cc1e7ca1699",
      "content": {
        "id": "8e47a6ba-5720-39ab-9b12-6cc1e7ca1699",
        "contentType": "STORY",
        "title": "Novo Nordisk Stock Price Falls After Ozempic Fails to Slow Alzheimer's",
        "description": "",
        "summary": "Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit weight-loss drugs didn't slow the progress of Alzheimer's disease.    Novo Nordisk stock recently stood about 10% lower, on pace for its lowest close since July 2021, according to Dow Jones Market Data.",
        "pubDate": "2025-11-24T12:16:22Z",
        "displayTime": "2025-11-24T12:16:22Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8e47a6ba-5720-39ab-9b12-6cc1e7ca1699/novo-nordisk-stock-price.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-24-2025/card/novo-nordisk-stock-price-falls-after-ozempic-fails-to-slow-alzheimer-s-dUT2l9aQtS1u7r0KxJQZ?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T10:53:00+00:00",
    "headline": "These Stocks Are Moving the Most Today: Tesla, Alphabet, Alibaba, Strategy, Eli Lilly, and More",
    "summary": "Stock futures were rising Monday with investors hopeful that economic data due this week will strengthen the case for the Federal Reserve to cut interest rates next month.  CEO Elon Musk said Sunday in a post on X that the electric-vehicle maker already had designed several million artificial-intelligence chips for its cars and data centers.  Tesla is close to finishing its AI5 chip, has started work on its AI6 chip, and is aiming to bring a new chip to volume production every 12 months, Musk added.",
    "url": "https://www.barrons.com/articles/stock-movers-37fe692a?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e8391264-b308-336f-9e5c-89bbd17a76f3",
      "content": {
        "id": "e8391264-b308-336f-9e5c-89bbd17a76f3",
        "contentType": "STORY",
        "title": "These Stocks Are Moving the Most Today: Tesla, Alphabet, Alibaba, Strategy, Eli Lilly, and More",
        "description": "",
        "summary": "Stock futures were rising Monday with investors hopeful that economic data due this week will strengthen the case for the Federal Reserve to cut interest rates next month.  CEO Elon Musk said Sunday in a post on X that the electric-vehicle maker already had designed several million artificial-intelligence chips for its cars and data centers.  Tesla is close to finishing its AI5 chip, has started work on its AI6 chip, and is aiming to bring a new chip to volume production every 12 months, Musk added.",
        "pubDate": "2025-11-24T10:53:00Z",
        "displayTime": "2025-11-24T10:53:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e8391264-b308-336f-9e5c-89bbd17a76f3/these-stocks-are-moving-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/3ca59d8914afa984af63f16053239638",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jwAkyjmFR03FANWo9YOSWQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/3ca59d8914afa984af63f16053239638.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Li546X3HiP_kcVLFyHoaVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/3ca59d8914afa984af63f16053239638.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-37fe692a?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "BABAF"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "BABA"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T13:06:40+00:00",
    "headline": "Ukraine peace, robotaxis and pharma: what's moving stocks",
    "summary": "The selloff in European defense stocks (BA.L, RHM.DE, HO.PA, BAB.L) deepens as hopes grow around a peace deal draft for Ukraine and Russia. China's robotaxi firm WeRide (WRD) rallies on a massive revenue jump - even though the firm is still burning cash. In pharma, after Eli Lilly (LLY) hit $1 trillion: Bayer (BAYN.DE) stock flies, Novo Nordisk (NVO, NOVO-B.CO) tanks. For more live coverage of the markets, watch the full episode of Market Sunrise and visit Yahoo Finance.",
    "url": "https://finance.yahoo.com/video/ukraine-peace-robotaxis-pharma-whats-130640017.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "f29f1aa4-1421-334e-8472-9ff9e560d7eb",
      "content": {
        "id": "f29f1aa4-1421-334e-8472-9ff9e560d7eb",
        "contentType": "VIDEO",
        "title": "Ukraine peace, robotaxis and pharma: what's moving stocks",
        "description": "<p>The selloff in European defense stocks (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/BA.L\">BA.L</a>, <a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/RHM.DE\">RHM.DE</a>, <a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/HO.PA\">HO.PA</a>, <a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/BAB.L\">BAB.L</a>) deepens as hopes grow around a peace deal draft for Ukraine and Russia. China's robotaxi firm WeRide (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/WRD\">WRD</a>) rallies on a massive revenue jump - even though the firm is still burning cash. In pharma, after Eli Lilly (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/LLY\">LLY</a>) hit $1 trillion: Bayer (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/BAYN.DE\">BAYN.DE</a>) stock flies, Novo Nordisk (<a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/quote/NVO\">NVO</a>, <a data-i13n=\"cpos:9;pos:1\" href=\"https://finance.yahoo.com/quote/NOVO-B.CO\">NOVO-B.CO</a>) tanks.</p>\n<p>For more live coverage of the markets, watch the full episode of <em>Market Sunrise</em> and visit<a data-i13n=\"cpos:10;pos:1\" href=\"https://finance.yahoo.com/\"> Yahoo Finance</a>.</p>",
        "summary": "The selloff in European defense stocks (BA.L, RHM.DE, HO.PA, BAB.L) deepens as hopes grow around a peace deal draft for Ukraine and Russia. China's robotaxi firm WeRide (WRD) rallies on a massive revenue jump - even though the firm is still burning cash. In pharma, after Eli Lilly (LLY) hit $1 trillion: Bayer (BAYN.DE) stock flies, Novo Nordisk (NVO, NOVO-B.CO) tanks. For more live coverage of the markets, watch the full episode of Market Sunrise and visit Yahoo Finance.",
        "pubDate": "2025-11-24T13:06:40Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/ae091030-c933-11f0-bb7e-cb870203f36b",
          "originalWidth": 3000,
          "originalHeight": 1689,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JGt8qeaK8y9LBJ2FbCLMAg--~B/aD0xNjg5O3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ae091030-c933-11f0-bb7e-cb870203f36b.cf.webp",
              "width": 3000,
              "height": 1689,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CNVngxzwpYOUME0ItWH1DQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ae091030-c933-11f0-bb7e-cb870203f36b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/ukraine-peace-robotaxis-pharma-whats-130640017.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/ukraine-peace-robotaxis-pharma-whats-130640017.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WRD"
            },
            {
              "symbol": "RNMBF"
            },
            {
              "symbol": "RNMBY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "BCKIF"
            },
            {
              "symbol": "BCKIY"
            },
            {
              "symbol": "BAESF"
            },
            {
              "symbol": "BAESY"
            },
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "BAYZF"
            },
            {
              "symbol": "THLEF"
            },
            {
              "symbol": "THLLY"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BAYN.DE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T13:30:36+00:00",
    "headline": "Stock Market Today: Dow Jones Rises; Google Pops On Salesforce Praise, Novo Nordisk Dives",
    "summary": "Futures rose Monday. Google popped amid Salesforce CEO Marc Benioff's praise for AI model Gemini 3. Novo Nordisk dived on Alzheimer's trial data.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp-500-nasdaq-google-gemini-3-salesforce-ceo-novo-nordisk/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e64b7da5-31cb-3d8e-94d3-671e0bc34c24",
      "content": {
        "id": "e64b7da5-31cb-3d8e-94d3-671e0bc34c24",
        "contentType": "STORY",
        "title": "Stock Market Today: Dow Jones Rises; Google Pops On Salesforce Praise, Novo Nordisk Dives",
        "description": "",
        "summary": "Futures rose Monday. Google popped amid Salesforce CEO Marc Benioff's praise for AI model Gemini 3. Novo Nordisk dived on Alzheimer's trial data.",
        "pubDate": "2025-11-24T13:30:36Z",
        "displayTime": "2025-11-24T13:30:36Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e64b7da5-31cb-3d8e-94d3-671e0bc34c24/stock-market-today-dow-jones.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/bf012397578831a262fee2360df31c19",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l5AO.Zvsmktyw7fbKTD3Ow--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/bf012397578831a262fee2360df31c19.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PZqsLojgxbAKrpEqfOX2gg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/bf012397578831a262fee2360df31c19.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp-500-nasdaq-google-gemini-3-salesforce-ceo-novo-nordisk/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "^NDX"
            },
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "CRM"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "OSCR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T12:00:00+00:00",
    "headline": "Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in",
    "summary": "Lilly's $1T valuation and soaring GLP-1 demand spotlight ETFs like IHE, PPH, MEDI, OZEM, MEDX and THNR for investors riding the weight-loss drug boom.",
    "url": "https://finance.yahoo.com/news/eli-lilly-hits-1-trillion-120000023.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2fb05fc7-085b-33e0-a7e3-bc2638079108",
      "content": {
        "id": "2fb05fc7-085b-33e0-a7e3-bc2638079108",
        "contentType": "STORY",
        "title": "Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in",
        "description": "",
        "summary": "Lilly's $1T valuation and soaring GLP-1 demand spotlight ETFs like IHE, PPH, MEDI, OZEM, MEDX and THNR for investors riding the weight-loss drug boom.",
        "pubDate": "2025-11-24T12:00:00Z",
        "displayTime": "2025-11-24T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MjuR.4zEKm0FgKsxK.lBKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.VCDKzJSEg_sv.1sSAJrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-hits-1-trillion-120000023.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-hits-1-trillion-120000023.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "THNR"
            },
            {
              "symbol": "PPH"
            },
            {
              "symbol": "OZEM"
            },
            {
              "symbol": "MEDI"
            },
            {
              "symbol": "IHE"
            },
            {
              "symbol": "MEDX"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T14:09:05+00:00",
    "headline": "Stock Market Today: Dow Jones Index Rises; Google Pops On Salesforce Praise, Novo Nordisk Dives",
    "summary": "Futures rose Monday. Google popped amid Salesforce CEO Marc Benioff's praise for AI model Gemini 3. Novo Nordisk dived on Alzheimer's trial data.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp-500-nasdaq-google-gemini-3-salesforce-ceo-novo-nordisk/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e64b7da5-31cb-3d8e-94d3-671e0bc34c24",
      "content": {
        "id": "e64b7da5-31cb-3d8e-94d3-671e0bc34c24",
        "contentType": "STORY",
        "title": "Stock Market Today: Dow Jones Index Rises; Google Pops On Salesforce Praise, Novo Nordisk Dives",
        "description": "",
        "summary": "Futures rose Monday. Google popped amid Salesforce CEO Marc Benioff's praise for AI model Gemini 3. Novo Nordisk dived on Alzheimer's trial data.",
        "pubDate": "2025-11-24T14:09:05Z",
        "displayTime": "2025-11-24T14:09:05Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e64b7da5-31cb-3d8e-94d3-671e0bc34c24/stock-market-today-dow-jones.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/bf012397578831a262fee2360df31c19",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l5AO.Zvsmktyw7fbKTD3Ow--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/bf012397578831a262fee2360df31c19.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PZqsLojgxbAKrpEqfOX2gg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/bf012397578831a262fee2360df31c19.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp-500-nasdaq-google-gemini-3-salesforce-ceo-novo-nordisk/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CRM"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "^NDX"
            },
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "OSCR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T13:38:00+00:00",
    "headline": "Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer’s Trials",
    "summary": "Oral semaglutide—a key ingredient in obesity and diabetes drugs Ozempic and Wegovy—didn’t slow Alzheimer’s disease in two late-stage clinical trials.",
    "url": "https://www.wsj.com/health/pharma/novo-nordisk-stock-ozempic-alzheimers-2fa7ed42?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "b395de5e-d4fd-396c-a317-453c164f32e9",
      "content": {
        "id": "b395de5e-d4fd-396c-a317-453c164f32e9",
        "contentType": "STORY",
        "title": "Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer’s Trials",
        "description": "",
        "summary": "Oral semaglutide—a key ingredient in obesity and diabetes drugs Ozempic and Wegovy—didn’t slow Alzheimer’s disease in two late-stage clinical trials.",
        "pubDate": "2025-11-24T13:38:00Z",
        "displayTime": "2025-11-24T13:38:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b395de5e-d4fd-396c-a317-453c164f32e9/novo-nordisk-shares-slump.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/f436ee80e5469330334b570101d93e97",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N5NugMfggPapZZeUwcSsMw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/f436ee80e5469330334b570101d93e97.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R1K5FkeVB7y7e56ROdPk8A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/f436ee80e5469330334b570101d93e97.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/novo-nordisk-stock-ozempic-alzheimers-2fa7ed42?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T13:16:00+00:00",
    "headline": "Lilly Crosses $1 Trillion Market Cap: Here's What Is Driving the Rally",
    "summary": "LLY hits a historic $1T valuation as booming GLP-1 sales from Mounjaro and Zepbound drive growth and expand momentum across its portfolio.",
    "url": "https://finance.yahoo.com/news/lilly-crosses-1-trillion-market-131600200.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "54568140-3315-39dc-a988-989183abe3a5",
      "content": {
        "id": "54568140-3315-39dc-a988-989183abe3a5",
        "contentType": "STORY",
        "title": "Lilly Crosses $1 Trillion Market Cap: Here's What Is Driving the Rally",
        "description": "",
        "summary": "LLY hits a historic $1T valuation as booming GLP-1 sales from Mounjaro and Zepbound drive growth and expand momentum across its portfolio.",
        "pubDate": "2025-11-24T13:16:00Z",
        "displayTime": "2025-11-24T13:16:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MjuR.4zEKm0FgKsxK.lBKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.VCDKzJSEg_sv.1sSAJrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lilly-crosses-1-trillion-market-131600200.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-crosses-1-trillion-market-131600200.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T12:35:00+00:00",
    "headline": "These Stocks Are Moving the Most Today: Tesla, Alphabet, Alibaba, Strategy, Novo Nordisk, Inspire Medical, and More",
    "summary": "Tesla rises after CEO Elon Musk indicates the electric-vehicle maker has designed AI chips for its cars and data centers.",
    "url": "https://www.barrons.com/articles/stock-movers-37fe692a?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e8391264-b308-336f-9e5c-89bbd17a76f3",
      "content": {
        "id": "e8391264-b308-336f-9e5c-89bbd17a76f3",
        "contentType": "STORY",
        "title": "These Stocks Are Moving the Most Today: Tesla, Alphabet, Alibaba, Strategy, Novo Nordisk, Inspire Medical, and More",
        "description": "",
        "summary": "Tesla rises after CEO Elon Musk indicates the electric-vehicle maker has designed AI chips for its cars and data centers.",
        "pubDate": "2025-11-24T12:35:00Z",
        "displayTime": "2025-11-24T12:35:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e8391264-b308-336f-9e5c-89bbd17a76f3/these-stocks-are-moving-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/3ca59d8914afa984af63f16053239638",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jwAkyjmFR03FANWo9YOSWQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/3ca59d8914afa984af63f16053239638.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Li546X3HiP_kcVLFyHoaVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/3ca59d8914afa984af63f16053239638.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-37fe692a?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "BABAF"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "BABA"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T14:53:32+00:00",
    "headline": "Stock Market Today: Dow Jones Falls, Techs Rally; Google Pops On Salesforce Praise, Novo Nordisk Dives",
    "summary": "The major indexes were mixed Monday. Google popped amid Salesforce CEO Marc Benioff's praise for AI model Gemini 3. Novo Nordisk dived on Alzheimer's trial data.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp-500-nasdaq-google-gemini-3-salesforce-ceo-novo-nordisk/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e64b7da5-31cb-3d8e-94d3-671e0bc34c24",
      "content": {
        "id": "e64b7da5-31cb-3d8e-94d3-671e0bc34c24",
        "contentType": "STORY",
        "title": "Stock Market Today: Dow Jones Falls, Techs Rally; Google Pops On Salesforce Praise, Novo Nordisk Dives",
        "description": "",
        "summary": "The major indexes were mixed Monday. Google popped amid Salesforce CEO Marc Benioff's praise for AI model Gemini 3. Novo Nordisk dived on Alzheimer's trial data.",
        "pubDate": "2025-11-24T14:53:32Z",
        "displayTime": "2025-11-24T14:53:32Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e64b7da5-31cb-3d8e-94d3-671e0bc34c24/stock-market-today-dow-jones.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/bf012397578831a262fee2360df31c19",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l5AO.Zvsmktyw7fbKTD3Ow--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/bf012397578831a262fee2360df31c19.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PZqsLojgxbAKrpEqfOX2gg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/bf012397578831a262fee2360df31c19.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp-500-nasdaq-google-gemini-3-salesforce-ceo-novo-nordisk/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "OSCR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T14:23:29+00:00",
    "headline": "Novo Dives After Weight-Loss Pill Fails In Alzheimer's Disease; Biogen Jumps",
    "summary": "Novo Nordisk stock plummeted Monday after its weight-loss pill failed to significantly slow the progression of Alzheimer's disease in two big studies.",
    "url": "https://www.investors.com/news/novo-nordisk-dives-ozempic-fails-slow-alzheimers-eli-lilly-biogen/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "a51cd60d-fe17-396c-bf06-7516a239f75c",
      "content": {
        "id": "a51cd60d-fe17-396c-bf06-7516a239f75c",
        "contentType": "STORY",
        "title": "Novo Dives After Weight-Loss Pill Fails In Alzheimer's Disease; Biogen Jumps",
        "description": "",
        "summary": "Novo Nordisk stock plummeted Monday after its weight-loss pill failed to significantly slow the progression of Alzheimer's disease in two big studies.",
        "pubDate": "2025-11-24T14:23:29Z",
        "displayTime": "2025-11-24T14:23:29Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a51cd60d-fe17-396c-bf06-7516a239f75c/novo-dives-after-weight-loss.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/817e6030ee2ae5f493a5abec2e2fbfba",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7obXGavYr8kgk3K.Mtzb2w--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/817e6030ee2ae5f493a5abec2e2fbfba.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jzjG937xziJt0639IwSv.A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/817e6030ee2ae5f493a5abec2e2fbfba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/novo-nordisk-dives-ozempic-fails-slow-alzheimers-eli-lilly-biogen/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "4523.T"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T16:09:29+00:00",
    "headline": "Eli Lilly Benefits From 'Broadening' GLP-1 Market, Morgan Stanley Says",
    "summary": "Eli Lilly (LLY) is benefiting from the \"broadening\" GLP-1 market for obesity and type-2 diabetes, Mo",
    "url": "https://finance.yahoo.com/news/eli-lilly-benefits-apos-broadening-160929450.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "57a9fe2c-21fc-37f0-a5a3-dde410c6aeab",
      "content": {
        "id": "57a9fe2c-21fc-37f0-a5a3-dde410c6aeab",
        "contentType": "STORY",
        "title": "Eli Lilly Benefits From 'Broadening' GLP-1 Market, Morgan Stanley Says",
        "description": "",
        "summary": "Eli Lilly (LLY) is benefiting from the \"broadening\" GLP-1 market for obesity and type-2 diabetes, Mo",
        "pubDate": "2025-11-24T16:09:29Z",
        "displayTime": "2025-11-24T16:09:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-benefits-apos-broadening-160929450.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-benefits-apos-broadening-160929450.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T15:42:15+00:00",
    "headline": "Stock Market Today: Dow, Nasdaq Rally; Health Care Plays Pop On Obamacare Hopes (Live Coverage)",
    "summary": "The major indexes rose Monday. Google popped amid Salesforce CEO Marc Benioff's praise for AI model Gemini 3. Novo Nordisk dived on Alzheimer's trial data.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp-500-nasdaq-google-gemini-3-salesforce-ceo-novo-nordisk/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e64b7da5-31cb-3d8e-94d3-671e0bc34c24",
      "content": {
        "id": "e64b7da5-31cb-3d8e-94d3-671e0bc34c24",
        "contentType": "STORY",
        "title": "Stock Market Today: Dow, Nasdaq Rally; Health Care Plays Pop On Obamacare Hopes (Live Coverage)",
        "description": "",
        "summary": "The major indexes rose Monday. Google popped amid Salesforce CEO Marc Benioff's praise for AI model Gemini 3. Novo Nordisk dived on Alzheimer's trial data.",
        "pubDate": "2025-11-24T15:42:15Z",
        "displayTime": "2025-11-24T15:42:15Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e64b7da5-31cb-3d8e-94d3-671e0bc34c24/stock-market-today-dow-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/f28d348f9516dd787376418c486867ca",
          "originalWidth": 1012,
          "originalHeight": 572,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lPCCq1m4e8U3HRoonXVHCg--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f28d348f9516dd787376418c486867ca.cf.webp",
              "width": 1012,
              "height": 572,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Bz9TZDomGMz0qt30pwbJ9Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/f28d348f9516dd787376418c486867ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp-500-nasdaq-google-gemini-3-salesforce-ceo-novo-nordisk/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "HD"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T15:40:00+00:00",
    "headline": "Novo Nordisk’s Alzheimer’s Trials Were a Long Shot. Their Failure Is Still Hitting the Stock.",
    "summary": "The drugmaker says an oral version of Wegovy improved Alzheimer’s-related biomarkers, but didn’t delay the disease’s progression.",
    "url": "https://www.barrons.com/articles/novo-nordisk-stock-ozempic-alzheimers-biogen-dbd2da9a?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "ddb0bac5-bbae-34e2-b8bd-93abfbe71273",
      "content": {
        "id": "ddb0bac5-bbae-34e2-b8bd-93abfbe71273",
        "contentType": "STORY",
        "title": "Novo Nordisk’s Alzheimer’s Trials Were a Long Shot. Their Failure Is Still Hitting the Stock.",
        "description": "",
        "summary": "The drugmaker says an oral version of Wegovy improved Alzheimer’s-related biomarkers, but didn’t delay the disease’s progression.",
        "pubDate": "2025-11-24T15:40:00Z",
        "displayTime": "2025-11-24T15:40:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ddb0bac5-bbae-34e2-b8bd-93abfbe71273/novo-nordisk%E2%80%99s-alzheimer%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/0fa126d231618bcc2aa15b1213f187d6",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dG.E5PjIwkwBUVEwfLIiUA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/0fa126d231618bcc2aa15b1213f187d6.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JBCAvaJOfP7JT31Dl73a6w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/0fa126d231618bcc2aa15b1213f187d6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/novo-nordisk-stock-ozempic-alzheimers-biogen-dbd2da9a?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T13:30:00+00:00",
    "headline": "Will NVO's U.S. Price Cuts Boost Access & Revive Semaglutide Demand?",
    "summary": "Novo Nordisk cuts self-pay prices for Wegovy and Ozempic in the United States, aiming to expand access and counter falling demand.",
    "url": "https://finance.yahoo.com/news/nvos-u-price-cuts-boost-133000873.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "968747a0-1a51-3acf-addb-b37fc23b6bbd",
      "content": {
        "id": "968747a0-1a51-3acf-addb-b37fc23b6bbd",
        "contentType": "STORY",
        "title": "Will NVO's U.S. Price Cuts Boost Access & Revive Semaglutide Demand?",
        "description": "",
        "summary": "Novo Nordisk cuts self-pay prices for Wegovy and Ozempic in the United States, aiming to expand access and counter falling demand.",
        "pubDate": "2025-11-24T13:30:00Z",
        "displayTime": "2025-11-24T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OpV4giEb4QjgN71LPYFzIw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QcLiFahMpkHBfBp4mOYpEQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nvos-u-price-cuts-boost-133000873.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nvos-u-price-cuts-boost-133000873.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T17:00:00+00:00",
    "headline": "Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting",
    "summary": "Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) Bruton tyrosine kinase (BTK) inhibitor, will be presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place Dec. 6-9 in Orlando, Florida.",
    "url": "https://finance.yahoo.com/news/lilly-present-data-two-positive-170000532.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "d9a09a76-cabc-3dce-9920-15ab043d217f",
      "content": {
        "id": "d9a09a76-cabc-3dce-9920-15ab043d217f",
        "contentType": "STORY",
        "title": "Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) Bruton tyrosine kinase (BTK) inhibitor, will be presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place Dec. 6-9 in Orlando, Florida.",
        "pubDate": "2025-11-24T17:00:00Z",
        "displayTime": "2025-11-24T17:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee",
          "originalWidth": 400,
          "originalHeight": 219,
          "caption": "Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7Y1fhfHoGbpYMTG8q90VAg--~B/aD0yMTk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee.cf.webp",
              "width": 400,
              "height": 219,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Goic7S8PJ1_UseTWpNhHw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lilly-present-data-two-positive-170000532.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-present-data-two-positive-170000532.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T16:59:34+00:00",
    "headline": "Eli Lilly flies the pharma flag in tech-heavy $1tn market cap club",
    "summary": "Fuelled by weight loss drug sales, Eli Lilly achieves a feat no healthcare company has before.",
    "url": "https://www.pharmaceutical-technology.com/news/eli-lilly-flies-the-pharma-flag-in-tech-heavy-1tn-market-cap-club/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "37185ec1-5ec3-33b9-b517-0c1d037d729b",
      "content": {
        "id": "37185ec1-5ec3-33b9-b517-0c1d037d729b",
        "contentType": "STORY",
        "title": "Eli Lilly flies the pharma flag in tech-heavy $1tn market cap club",
        "description": "",
        "summary": "Fuelled by weight loss drug sales, Eli Lilly achieves a feat no healthcare company has before.",
        "pubDate": "2025-11-24T16:59:34Z",
        "displayTime": "2025-11-24T16:59:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/0a48ff53c5ca58539c1ca91537e0eb85",
          "originalWidth": 1000,
          "originalHeight": 666,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UR27IZqVceuOEaLZ7Fl1.Q--~B/aD02NjY7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/0a48ff53c5ca58539c1ca91537e0eb85.cf.webp",
              "width": 1000,
              "height": 666,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KNqZEYArnQtXrsFzg.rbzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/0a48ff53c5ca58539c1ca91537e0eb85.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/eli-lilly-flies-the-pharma-flag-in-tech-heavy-1tn-market-cap-club/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-flies-pharma-flag-165934393.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T16:46:25+00:00",
    "headline": "Novo's $5 Billion Alzheimer's Dream Just Died--And Investors Are Cratering the Stock",
    "summary": "A long-shot Ozempic trial collapse sends Novo Nordisk to its lowest levels since 2021, reigniting market fears.",
    "url": "https://finance.yahoo.com/news/novos-5-billion-alzheimers-dream-164625711.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "b5f7b365-8ec1-31e8-b910-5b622eb18537",
      "content": {
        "id": "b5f7b365-8ec1-31e8-b910-5b622eb18537",
        "contentType": "STORY",
        "title": "Novo's $5 Billion Alzheimer's Dream Just Died--And Investors Are Cratering the Stock",
        "description": "",
        "summary": "A long-shot Ozempic trial collapse sends Novo Nordisk to its lowest levels since 2021, reigniting market fears.",
        "pubDate": "2025-11-24T16:46:25Z",
        "displayTime": "2025-11-24T16:46:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9TzR39bxuUCR99sbuZJDMQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NjQrAqlrjUwsW.v1rUBg.Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/7e63317195f3cefdce4c30843a9d7c57.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novos-5-billion-alzheimers-dream-164625711.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novos-5-billion-alzheimers-dream-164625711.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T16:34:00+00:00",
    "headline": "Novo Nordisk Stock Falls. Why Its Alzheimer’s Trial News Is Hitting Shares.",
    "summary": "The drugmaker says an oral version of Wegovy improved Alzheimer’s-related biomarkers, but didn’t delay the disease’s progression.",
    "url": "https://www.barrons.com/articles/novo-nordisk-stock-price-ozempic-alzheimers-news-dbd2da9a?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "ddb0bac5-bbae-34e2-b8bd-93abfbe71273",
      "content": {
        "id": "ddb0bac5-bbae-34e2-b8bd-93abfbe71273",
        "contentType": "STORY",
        "title": "Novo Nordisk Stock Falls. Why Its Alzheimer’s Trial News Is Hitting Shares.",
        "description": "",
        "summary": "The drugmaker says an oral version of Wegovy improved Alzheimer’s-related biomarkers, but didn’t delay the disease’s progression.",
        "pubDate": "2025-11-24T16:34:00Z",
        "displayTime": "2025-11-24T16:34:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ddb0bac5-bbae-34e2-b8bd-93abfbe71273/novo-nordisk-stock-falls-why.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/0fa126d231618bcc2aa15b1213f187d6",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dG.E5PjIwkwBUVEwfLIiUA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/0fa126d231618bcc2aa15b1213f187d6.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JBCAvaJOfP7JT31Dl73a6w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/0fa126d231618bcc2aa15b1213f187d6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/novo-nordisk-stock-price-ozempic-alzheimers-news-dbd2da9a?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]